Ecolab reported higher third-quarter sales on October 27 and narrowed its full-year adjusted earnings forecast, according to its results release.
Sales reached $4.695 billion, up 13% from a year earlier. Organic sales, which exclude acquisition and currency effects, increased 7%. The company attributed that organic gain to 2% volume growth and 5% pricing growth.
Reported net income fell to $551.3 million from $585 million. Diluted earnings declined to $1.95 per share from $2.05. Adjusted earnings, a separate measure that excludes specified items, rose to $2.18 per share from $2.07.
The company said higher acquisition-related financing and amortization costs weighed on earnings growth. Global High-Tech organic sales increased 63%, and Life Sciences grew 17%.
Ecolab now expects full-year adjusted earnings of $8.10–$8.20 per share, compared with its previous $8.03–$8.23 range. Its fourth-quarter forecast is $2.13–$2.23. These projections describe management’s expectations rather than completed results.
Sources: Ecolab results release, distributed by Business Wire: https://www.stocktitan.net/news/ECL/ecolab-delivers-strong-and-accelerating-operating-performance-pfwf8ixrkenv.html Benzinga earnings report: https://www.benzinga.com/markets/earnings/26/10/62617671/ecolab-q3-earnings-beat-estimates-sales-miss-company-narrows-2026-outlook